VASH1 Antikörper (AA 3-100)
Kurzübersicht für VASH1 Antikörper (AA 3-100) (ABIN524800)
Target
Alle VASH1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 3-100
-
Verwendungszweck
- Mouse monoclonal antibody raised against a partial recombinant VASH1.
-
Sequenz
- GGKKVAGGGS SGATPTSAAA TAPSGVRRLE TSEGTSAQRD EEPEEEGEED LRDGGVPFFV NRGGLPVDEA TWERMWKHVA KIHPDGEKVA QRIRGATD
-
Kreuzreaktivität
- Human
-
Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
-
Immunogen
- VASH1 (NP_055724, 3 a.a. ~ 100 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
-
Isotyp
- IgG2a
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- In 1x PBS, pH 7.4
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
-
Keratin 19 as a key molecule in progression of human hepatocellular carcinomas through invasion and angiogenesis." in: BMC cancer, Vol. 16, Issue 1, pp. 903, (2016) (PubMed).
: "Vasohibin-1 increases the malignant potential of colorectal cancer and is a biomarker of poor prognosis." in: Anticancer research, Vol. 34, Issue 10, pp. 5321-9, (2014) (PubMed).
: "Upregulation of vasohibin-1 expression with angiogenesis and poor prognosis of hepatocellular carcinoma after curative surgery." in: Medical oncology (Northwood, London, England), Vol. 29, Issue 4, pp. 2727-36, (2012) (PubMed).
: "
-
Keratin 19 as a key molecule in progression of human hepatocellular carcinomas through invasion and angiogenesis." in: BMC cancer, Vol. 16, Issue 1, pp. 903, (2016) (PubMed).
-
- VASH1 (Vasohibin 1 (VASH1))
-
Andere Bezeichnung
- VASH1
-
Hintergrund
-
Full Gene Name: vasohibin 1
Synonyms: KIAA1036 -
Gen-ID
- 22846
-
NCBI Accession
- NM_014909
Target
-